1. Home
  2. KMDA vs LAND Comparison

KMDA vs LAND Comparison

Compare KMDA & LAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • LAND
  • Stock Information
  • Founded
  • KMDA 1990
  • LAND 1997
  • Country
  • KMDA Israel
  • LAND United States
  • Employees
  • KMDA N/A
  • LAND N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • LAND Real Estate Investment Trusts
  • Sector
  • KMDA Health Care
  • LAND Real Estate
  • Exchange
  • KMDA Nasdaq
  • LAND Nasdaq
  • Market Cap
  • KMDA 398.5M
  • LAND 360.0M
  • IPO Year
  • KMDA N/A
  • LAND 2013
  • Fundamental
  • Price
  • KMDA $6.62
  • LAND $9.38
  • Analyst Decision
  • KMDA Strong Buy
  • LAND
  • Analyst Count
  • KMDA 2
  • LAND 0
  • Target Price
  • KMDA $13.00
  • LAND N/A
  • AVG Volume (30 Days)
  • KMDA 70.7K
  • LAND 353.7K
  • Earning Date
  • KMDA 11-10-2025
  • LAND 11-05-2025
  • Dividend Yield
  • KMDA 3.00%
  • LAND 5.97%
  • EPS Growth
  • KMDA 27.97
  • LAND N/A
  • EPS
  • KMDA 0.32
  • LAND N/A
  • Revenue
  • KMDA $169,517,000.00
  • LAND $67,921,000.00
  • Revenue This Year
  • KMDA $14.49
  • LAND N/A
  • Revenue Next Year
  • KMDA $10.12
  • LAND $15.78
  • P/E Ratio
  • KMDA $20.13
  • LAND N/A
  • Revenue Growth
  • KMDA 9.67
  • LAND N/A
  • 52 Week Low
  • KMDA $5.54
  • LAND $8.47
  • 52 Week High
  • KMDA $9.16
  • LAND $13.73
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 42.74
  • LAND 58.11
  • Support Level
  • KMDA $6.66
  • LAND $8.82
  • Resistance Level
  • KMDA $6.93
  • LAND $9.50
  • Average True Range (ATR)
  • KMDA 0.17
  • LAND 0.20
  • MACD
  • KMDA -0.02
  • LAND 0.03
  • Stochastic Oscillator
  • KMDA 10.71
  • LAND 75.74

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About LAND Gladstone Land Corporation

Gladstone Land Corp is an externally-managed, agricultural REIT. It is mainly in the business of owning and leasing farmland. It manages operations in one reporting segment. It is focused on the ownership of high-quality farms and farm-related properties that are leased on a triple-net basis to tenants with a good operating history and deep farming resources. The farmland is predominantly concentrated in locations where farmers are able to grow either fresh produce annual row crops (e.g., certain berries and vegetables), which are typically planted and harvested annually, or certain permanent crops (e.g., almonds, blueberries, pistachios, and wine grapes). To a much lesser extent, it also own farms that grow certain commodity crops (e.g., corn and beans).

Share on Social Networks: